Press release
Digital Insomnia Therapeutics Market Offers a Restful Future Sleepless No More
Digital Insomnia Therapeutics Market
Digital Insomnia Therapeutics Market to reach over USD 5.15 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Insomnia Therapeutics Market Size, Share & Trends Analysis Report By Type (Sleep Tracking Apps. Relaxation and Meditation Apps, CBT-I, Wearable Devices), Distribution Channel (Mobile App Stores, Healthcare Providers and Clinics, and Other Distribution Channels) , Region, Market Outlook And Industry Analysis 2031"
The global Digital Insomnia Therapeutics market is estimated to reach over USD 5.15 billion by 2024-2031, exhibiting a CAGR of 5.57% during the forecast period.
Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1873
Sleepless Nights No More: The Insomnia Treatment Market Seeks Solutions (2024 and Beyond)
Insomnia, the inability to fall asleep or stay asleep, disrupts the lives of millions worldwide. Symptoms like low energy, fatigue, depression, and irritability can significantly impact daily functioning.
Understanding the Causes: A Complex Web
Several factors can lead to insomnia, including:
• Disrupted Circadian Rhythm: This internal clock regulates sleep-wake cycles. Disruptions due to jet lag, shift work, or screen time before bed can cause insomnia.
• Medical Conditions: Certain medical conditions like menopause, hyperthyroidism, chronic pain, and psychological stress can contribute to sleep difficulties.
• Substance Abuse: Excessive use of alcohol, nicotine, and caffeine can interfere with sleep.
Diagnosing the Problem: A Path to Treatment
Sleep labs use sophisticated diagnostic techniques to pinpoint the cause of insomnia and guide treatment plans.
A Market Poised for Growth: A Promising Future
The insomnia treatment market is driven by various factors:
• Technological Advancements: New medical devices and sleep monitoring technology are aiding diagnosis and treatment.
• Aging Population: The growing elderly population, more susceptible to sleep disturbances, creates a larger market base.
• Novel Medications: The availability of patented sleep medications and promising drugs in clinical trials fuels market growth.
• Heightened Awareness: Increasing awareness of the negative health consequences of sleep deprivation is driving demand for effective insomnia treatments.
The Road Ahead: A Good Night's Rest for All
The insomnia treatment market presents a significant opportunity to improve sleep health for millions. As research continues to explore the causes of insomnia and develop innovative solutions, the future appears brighter for a good night's rest.
List of Prominent Players in the Digital Insomnia Therapeutics Market:
• Curv Health
• Bodymatter, Inc.
• PrimeNap
• Headspace Inc.
• Big Health
• Calm
• Nox Health
• Pear Therapeutics Inc.
• OPTT Inc.
• SilverCloud
Market Dynamics:
Drivers-
The demand for digital therapeutics is increasing due to their benefits, including their ability to change behavior, be user-friendly, convenient for patients, and improve drug compliance, as well as new technological developments in digital therapeutics. Due to their benefits, such as their ability to change behavior, be user-friendly, convenient for patients, and enhance drug compliance, digital therapies are in high demand.
The use of healthcare applications to diagnose, treat, and manage illness is spreading along with the proliferation of smartphones and tablets. It allows for the simple recording and monitoring of patients' vital signs without the need for intervention. Mobile consultations are made possible, and chronic disease management is made effective. Digital medicines offer the chance to lengthen product life cycles, distinguish items in development, and close market gaps caused by traditional medication.
Challenges:
Regulator-related problems with digital therapies' approval, validation, and payment are common. Different frameworks or standards may be used by regulatory agencies to evaluate and approve digital interventions, which might pose obstacles to market entry and wide adoption. Additionally, despite the potential of digital insomnia therapies, more study and validation may be required to confirm their efficacy and safety. For a product to be approved by regulatory organizations, medical professionals, and other stakeholders, strong clinical trials and evidence are required.
Regional Trends:
In terms of revenue, the market for drugs to treat insomnia was dominated by North America. The market is anticipated to be fueled by rising healthcare costs, an increase in the prevalence of sleep disorders, greater public awareness, and rising demand for sleep disorder treatment in the US and Canada.
Additionally, the country's rapidly growing senior population and the high prevalence of this ailment in the elderly community are projected to drive up demand. Supportive reimbursement policies for therapeutic treatments, a strong clinical pipeline, and increased stress levels are further factors predicted to drive revenue growth.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1873
Recent Developments:
• In May 2022, QUVIVIQ, which is intended for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and a significant impact on daytime functioning, was given marketing permission by the European Commission to Idorsia Ltd.
• In January 2022, The United States Food and Drug Administration gave Idorsia permission to market QUVIVIQ 25 and 50 mg for the treatment of individuals with insomnia who have trouble falling asleep or staying asleep.
Segmentation of Digital Insomnia Therapeutics Market-
By Type-
• Sleep Tracking Apps
• Relaxation and Meditation Apps
• Cognitive-Behavioral Therapy for Insomnia (CBT-I)
• Wearable Devices
• Others
By Distribution Channel-
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channel
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/report/digital-insomnia-therapeutics-market-/1873
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Digital Insomnia Therapeutics Market to reach over USD 5.15 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Insomnia Therapeutics Market Size, Share & Trends Analysis Report By Type (Sleep Tracking Apps. Relaxation and Meditation Apps, CBT-I, Wearable Devices), Distribution Channel (Mobile App Stores, Healthcare Providers and Clinics, and Other Distribution Channels) , Region, Market Outlook And Industry Analysis 2031"
The global Digital Insomnia Therapeutics market is estimated to reach over USD 5.15 billion by 2024-2031, exhibiting a CAGR of 5.57% during the forecast period.
Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1873
Sleepless Nights No More: The Insomnia Treatment Market Seeks Solutions (2024 and Beyond)
Insomnia, the inability to fall asleep or stay asleep, disrupts the lives of millions worldwide. Symptoms like low energy, fatigue, depression, and irritability can significantly impact daily functioning.
Understanding the Causes: A Complex Web
Several factors can lead to insomnia, including:
• Disrupted Circadian Rhythm: This internal clock regulates sleep-wake cycles. Disruptions due to jet lag, shift work, or screen time before bed can cause insomnia.
• Medical Conditions: Certain medical conditions like menopause, hyperthyroidism, chronic pain, and psychological stress can contribute to sleep difficulties.
• Substance Abuse: Excessive use of alcohol, nicotine, and caffeine can interfere with sleep.
Diagnosing the Problem: A Path to Treatment
Sleep labs use sophisticated diagnostic techniques to pinpoint the cause of insomnia and guide treatment plans.
A Market Poised for Growth: A Promising Future
The insomnia treatment market is driven by various factors:
• Technological Advancements: New medical devices and sleep monitoring technology are aiding diagnosis and treatment.
• Aging Population: The growing elderly population, more susceptible to sleep disturbances, creates a larger market base.
• Novel Medications: The availability of patented sleep medications and promising drugs in clinical trials fuels market growth.
• Heightened Awareness: Increasing awareness of the negative health consequences of sleep deprivation is driving demand for effective insomnia treatments.
The Road Ahead: A Good Night's Rest for All
The insomnia treatment market presents a significant opportunity to improve sleep health for millions. As research continues to explore the causes of insomnia and develop innovative solutions, the future appears brighter for a good night's rest.
List of Prominent Players in the Digital Insomnia Therapeutics Market:
• Curv Health
• Bodymatter, Inc.
• PrimeNap
• Headspace Inc.
• Big Health
• Calm
• Nox Health
• Pear Therapeutics Inc.
• OPTT Inc.
• SilverCloud
Market Dynamics:
Drivers-
The demand for digital therapeutics is increasing due to their benefits, including their ability to change behavior, be user-friendly, convenient for patients, and improve drug compliance, as well as new technological developments in digital therapeutics. Due to their benefits, such as their ability to change behavior, be user-friendly, convenient for patients, and enhance drug compliance, digital therapies are in high demand.
The use of healthcare applications to diagnose, treat, and manage illness is spreading along with the proliferation of smartphones and tablets. It allows for the simple recording and monitoring of patients' vital signs without the need for intervention. Mobile consultations are made possible, and chronic disease management is made effective. Digital medicines offer the chance to lengthen product life cycles, distinguish items in development, and close market gaps caused by traditional medication.
Challenges:
Regulator-related problems with digital therapies' approval, validation, and payment are common. Different frameworks or standards may be used by regulatory agencies to evaluate and approve digital interventions, which might pose obstacles to market entry and wide adoption. Additionally, despite the potential of digital insomnia therapies, more study and validation may be required to confirm their efficacy and safety. For a product to be approved by regulatory organizations, medical professionals, and other stakeholders, strong clinical trials and evidence are required.
Regional Trends:
In terms of revenue, the market for drugs to treat insomnia was dominated by North America. The market is anticipated to be fueled by rising healthcare costs, an increase in the prevalence of sleep disorders, greater public awareness, and rising demand for sleep disorder treatment in the US and Canada.
Additionally, the country's rapidly growing senior population and the high prevalence of this ailment in the elderly community are projected to drive up demand. Supportive reimbursement policies for therapeutic treatments, a strong clinical pipeline, and increased stress levels are further factors predicted to drive revenue growth.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1873
Recent Developments:
• In May 2022, QUVIVIQ, which is intended for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and a significant impact on daytime functioning, was given marketing permission by the European Commission to Idorsia Ltd.
• In January 2022, The United States Food and Drug Administration gave Idorsia permission to market QUVIVIQ 25 and 50 mg for the treatment of individuals with insomnia who have trouble falling asleep or staying asleep.
Segmentation of Digital Insomnia Therapeutics Market-
By Type-
• Sleep Tracking Apps
• Relaxation and Meditation Apps
• Cognitive-Behavioral Therapy for Insomnia (CBT-I)
• Wearable Devices
• Others
By Distribution Channel-
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channel
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/report/digital-insomnia-therapeutics-market-/1873
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
